Incidence and Malignancy Rates in Thyroid Nodules in North-East Indian Population by Bethesda System: A Single Institutional Experience of 3 Years

被引:1
|
作者
Chakraborty, Suvamoy [1 ]
Balakrishnan, Manu C. [1 ]
Raphael, Vandana [2 ]
Tamuli, Prachurya [1 ]
Deka, Anuradha [1 ]
机构
[1] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Dept Otorhinolaryngol, Shillong 793018, Meghalaya, India
[2] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Dept Pathol, Shillong, Meghalaya, India
关键词
biopsy; cytodiagnosis; fine needle; goiter; thyroid neoplasms; thyroid nodule; NEEDLE-ASPIRATION-CYTOLOGY; CYTOPATHOLOGY; CATEGORIES;
D O I
10.1055/s-0042-1757776
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Goiter is one of the most common conditions encountered clinically (up to 60% of population) with thyroid malignancy being one of the most common endocrine malignancies. The American Thyroid Association has advocated the need for validation of the Bethesda system of fine needle aspiration cytology (FNAC) in each center. The risk of malignancy (ROM) for Bethesda categories in the Indian population is limited. Objective As there are variations in the effectiveness of FNAC, this study aims to study the role of FNAC in evaluating thyroid nodules, estimating the risk of malignancy in thyroid nodules in the North-East Indian population, and correlating the FNAC findings with HPE (histopathological examination). Materials and Methods A total of 110 patients with thyroid nodules had visited the Department of Otorhinolaryngology during 2017-2020. Case records were retrieved, out of which only 66 patients had both FNAC and HPE reports. The FNAC of 66 patients were studied. Statistical Analysis Data were analyzed using STATA V14. Fischer's exact test was used to determine the association of Bethesda system in diagnosing thyroid malignancy. The percentage agreement between the FNAC and HPE was calculated using the Kappa statistics. The diagnostic validity of FNAC in the diagnosis of malignant thyroid nodule was reported. Results The sensitivity, specificity, PPV, and NPV of FNAC in diagnosing thyroid malignancy were 52%, 94.3%, 89%, and 69% respectively. The risk of malignancy (ROM) for Bethesda I to VI categories in our study was 20%, 25%, 67%, 40%, 78%, and 100% respectively (p-value < 0.001, Fischer's exact test). Conclusion A specificity of 94.3% and PPV of 89% of FNAC makes it a good reliable tool in ruling in malignancy in our population. The higher ROM in indeterminate categories necessitates the need to consider thyroidectomy with or without intraoperative frozen section analysis in our population. Similar higher ROM has been reported in a few other Indian studies. These findings may suggest an increased ROM for Bethesda categories III and IV in the Indian population; however, the statement needs further validation from large multicentric studies with research to find the reason for the increased risk.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 39 条
  • [1] A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
    Arul, P.
    Akshatha, C.
    Masilamani, Suresh
    BIOMEDICAL JOURNAL, 2015, 38 (06) : 517 - 522
  • [2] Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate:An institutional experience
    Almahari, Sayed Ali
    Harb, Zainab
    Alshaikh, Safa
    CYTOJOURNAL, 2019, 16
  • [3] Accuracy of the 'CUT' Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study
    Shihabi, Areej N.
    Hussein, Mohammad
    Toraih, Eman A.
    Attia, Abdallah S.
    Youssef, Mohanad R.
    Elnahla, Ahmed
    Omar, Mahmoud
    Shama, Mohamed
    Corsetti, Ralph
    Kandil, Emad
    CANCER INVESTIGATION, 2022, 40 (08) : 693 - +
  • [4] Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting
    Guo, Aili
    Kaminoh, Yuuki
    Forward, Terra
    Schwartz, Frank L.
    Jenkinson, Scott
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [5] Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand
    Thewjitcharoen, Yotsapon
    Butadej, Siriwan
    Nakasatien, Soontaree
    Chotwanvirat, Phawinpon
    Porramatikul, Sriurai
    Krittiyawong, Sirinate
    Lekpittaya, Nampetch
    Himathongkam, Thep
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 16
  • [6] Molecular Testing for Bethesda III Thyroid Nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution
    Stillman, Mason D.
    Kuo, Eric J.
    Liou, Rachel
    Almuqate, Abdullah
    Virk, Renu
    Lee, James A.
    Kuo, Jennifer H.
    McManus, Catherine M.
    THYROID, 2024, 34 (04) : 460 - 466
  • [7] The combination of ACR-Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules-An institutional experience
    Sakthisankari, Shanmugasundaram
    Vidhyalakshmi, Sreenivasan
    Shanthakumari, Sivanandam
    Devanand, Balalakshmoji
    Nagul, Udayasankar
    CYTOPATHOLOGY, 2021, 32 (04) : 472 - 481
  • [8] Pediatric thyroid nodules: a multi-institutional study from India based on the applicability of the Bethesda System with analysis of the risk of malignancy (ROM) and comparison with adult thyroid nodules
    Rana, C.
    Nigam, N.
    Agarwal, S.
    Mishra, P.
    Bychkov, A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S35 - S35
  • [9] The Bethesda System for Reporting Thyroid Cytopathology: A Single Center Experience over Five Years
    Kiernan, C. M.
    Broome, J. T.
    Solorzano, C. C.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S17 - S17
  • [10] Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian Reporting System for Thyroid Cytology: An institutional experience
    Straccia, P.
    Santoro, A.
    Rossi, E. D.
    Brunelli, C.
    Mosseri, C.
    Musarra, T.
    Pontecorvi, A.
    Lombardi, C. P.
    Fadda, G.
    CYTOPATHOLOGY, 2017, 28 (06) : 503 - 508